RT @TheLancetRheum: Editors Pick for #ACR20—Leflunomide–hydroxychloroquine combination therapy in patients with prim

Social Author Image
https://pbs.twimg.com/profile_images/1117737372827910146/fI-WDgjl.png
Tweet Author
TheLancetRheum
Social Author Name
The Lancet Rheumatology
Tweet Content
Editors Pick for #ACR20—Leflunomide–hydroxychloroquine combination therapy in patients with primary Sjögren's syndrome (RepurpSS-I): a placebo-controlled, double-blinded, randomised clinical trial https://t.co/cunDxVl5XG https://t.co/OGItXCuWDI
Links
DEFINE_ME https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30057-6/full…
Show on Archive Page
On
Display in Search Results
On

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright {{ 'now'|date('Y') }} All Rights Reserved.